| |
 |
|
Class Information
Number: 424/135.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Structurally-modified antibody, immunoglobulin, or fragment thereof (e.g., chimeric, humanized, cdr-grafted, mutated, etc.) > Single chain antibody
Description: Subject matter wherein the material is a single polypeptide chain that has antigen-binding capability.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618625 |
Compositions comprising large and small binding fragments of antibodies against the same toxin |
Nov. 17, 2009 |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615218 |
Methods for determining and lowering caffeine concentration in fluids |
Nov. 10, 2009 |
| 7608269 |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
Oct. 27, 2009 |
| 7601352 |
Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA |
Oct. 13, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7595046 |
Treatment of cancer using anti-Apo-2 antibodies |
Sep. 29, 2009 |
| 7589182 |
Anti-sulfotyrosine antibodies |
Sep. 15, 2009 |
| 7585500 |
Fully human monoclonal antibodies to IL-13 |
Sep. 8, 2009 |
| 7585505 |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
Sep. 8, 2009 |
| 7578999 |
Antibodies specific for sclerostin |
Aug. 25, 2009 |
| 7579000 |
Tissue factor targeted antibodies as anticoagulants |
Aug. 25, 2009 |
| 7575923 |
CD19xCD3 specific polypeptides and uses thereof |
Aug. 18, 2009 |
| 7566451 |
Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency |
Jul. 28, 2009 |
| 7563443 |
Monovalent anti-CD40L antibody polypeptides and compositions thereof |
Jul. 21, 2009 |
| 7563874 |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
Jul. 21, 2009 |
| 7553936 |
Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions |
Jun. 30, 2009 |
| RE40811 |
Peripheralization of hematopoietic stem cells |
Jun. 30, 2009 |
| 7547437 |
Method of treating fibrosis |
Jun. 16, 2009 |
| 7534427 |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
May. 19, 2009 |
| 7534431 |
Methods and compositions for administering therapeutic and diagnostic agents |
May. 19, 2009 |
| 7531169 |
High affinity anti-human IgE antibodies |
May. 12, 2009 |
| 7531168 |
Method for downmodulating immune response in type I diabetes |
May. 12, 2009 |
| 7521056 |
Stably tethered structures of defined compositions with multiple functions or binding specificities |
Apr. 21, 2009 |
| 7517965 |
Non-neutralizing anti-aPC antibodies |
Apr. 14, 2009 |
| 7514077 |
Methods of antagonizing signal transduction in dorsal root ganglion cells with IL-31 antagonists |
Apr. 7, 2009 |
| 7514079 |
Antibodies that specifically bind to neurokinin B |
Apr. 7, 2009 |
| 7510707 |
PAR, a novel marker gene for breast and prostate cancers |
Mar. 31, 2009 |
| 7507796 |
Multivalent antibody constructs |
Mar. 24, 2009 |
| 7507408 |
Anti hepatitis C virus antibody and uses thereof |
Mar. 24, 2009 |
| 7501122 |
Treatment with anti-ErbB2 antibody combinations |
Mar. 10, 2009 |
| 7498030 |
Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
Mar. 3, 2009 |
| 7488477 |
Neutralizing monoclonal antibodies to respiratory syncytial virus |
Feb. 10, 2009 |
| 7488802 |
Antibodies against PD-1 |
Feb. 10, 2009 |
| 7485302 |
Treatment with anti-ErbB2 antibodies and chemotherapeutic agents |
Feb. 3, 2009 |
| 7476384 |
Death domain containing receptor 4 antibody and methods |
Jan. 13, 2009 |
| 7470775 |
Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins |
Dec. 30, 2008 |
| 7465444 |
Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM |
Dec. 16, 2008 |
| 7465445 |
Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM |
Dec. 16, 2008 |
| 7452536 |
Methods of treating cancer by administering antibodies to CD200 |
Nov. 18, 2008 |
| 7446191 |
DNA construct encoding CE7-specific chimeric T cell receptor |
Nov. 4, 2008 |
| 7438905 |
Methods of suppressing, treating, or preventing graft rejection with an antibody or a portion thereof that binds to AILIM |
Oct. 21, 2008 |
| 7435799 |
TNF-.alpha. binding molecules |
Oct. 14, 2008 |
| 7435796 |
Antibodies which bind B7RP1 |
Oct. 14, 2008 |
| 7435412 |
Chronic lymphocytic leukemia cell line |
Oct. 14, 2008 |
| 7431927 |
TNF.alpha.-neutralizing antibodies |
Oct. 7, 2008 |
| 7425619 |
Fc.gamma.RIIB specific antibodies and methods of use thereof |
Sep. 16, 2008 |
|
|
|
